Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

110.65
-0.3500-0.32%
Pre-market: 110.07-0.5800-0.52%05:19 EDT
Volume:547.97K
Turnover:60.41M
Market Cap:26.56B
PE:-32.10
High:111.81
Open:111.00
Low:108.72
Close:111.00
Loading ...

BioNTech price target lowered to $126 from $127 at BofA

TIPRANKS
·
1 hour ago

BioNTech SE (BNTX) Gets a Buy from Bank of America Securities

TIPRANKS
·
1 hour ago

European Equities Traded in the US as ADRs Edge Up in Monday Trading

MT Newswires Live
·
14 Jul

Pfizer’s New Study on COVID-19 Vaccine Effectiveness: What Investors Need to Know

TIPRANKS
·
12 Jul

GSK’s Innovative Flu/COVID-19 Combo Vaccine Study Completes: Market Implications

TIPRANKS
·
12 Jul

BioNTech’s Promising Trial: BNT113 and Pembrolizumab in Head and Neck Cancer

TIPRANKS
·
12 Jul

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires Live
·
11 Jul

Genmab and BioNTech’s Immunoradiotherapy Study: A Potential Game-Changer in Cancer Treatment

TIPRANKS
·
11 Jul

BioNTech Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
11 Jul

Market Chatter: BioNTech, Pfizer Urge UK Court to Overturn Moderna Vaccine Patent Ruling

MT Newswires Live
·
10 Jul

Warburg Research Sticks to Its Hold Rating for Deutsche Boerse (0H3T)

TIPRANKS
·
10 Jul

BioNTech’s Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment

TIPRANKS
·
10 Jul

Bayhorse Silver Addresses Insider Disclosure Errors Amidst COVID-19 Challenges

TIPRANKS
·
09 Jul

Moderna Stock Is Climbing. It Has Been a Tumultuous Few Days for Pharma. -- Barrons.com

Dow Jones
·
09 Jul

How Australia should respond to Trump’s tariff deadline

The Australian Financial Review
·
07 Jul

How my SMSF beat big super without buying CBA

The Australian Financial Review
·
06 Jul

How Much of Your Portfolio Should Be in International Stocks? -- Journal Report

Dow Jones
·
04 Jul

Analysis: If the "Beautiful Law Act" is likened to a flood released for the COVID-19 pandemic, Bitcoin could potentially rise to $150,000

Blockbeats
·
04 Jul

BioNTech SE’s BNT317 Study: A New Hope for Advanced Solid Tumors

TIPRANKS
·
04 Jul

3 Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 9% -- Which Make for No-Brainer Buys in July

Motley Fool
·
03 Jul